Home
Accord Healthcare, Inc.

Accord Healthcare, Inc. Market Share Analysis for July 2026

Accord Healthcare is a global provider of generic and specialty pharmaceuticals. Our focus on a rapidly expanding portfolio of affordable generic

Health > Pharmacy

Domainaccordhealthcare.us

Year Founded1976

Employees201 - 500

Annual Revenue--

Accord Healthcare, Inc.

Accord Healthcare, Inc. (including company regionals)

accordhealthcare.us

See more website traffic and engagement information

Total visits to Accord Healthcare, Inc.'s top domains

Understand Accord Healthcare, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

accordhealthcare.us6.1K

See more with Sales Intelligence

Avg. visit duration in Accord Healthcare, Inc.'s top domains

Analyze Accord Healthcare, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

accordhealthcare.us00:00:27

See more with Sales Intelligence

Avg. pageviews on Accord Healthcare, Inc.'s top domains

See how Accord Healthcare, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

accordhealthcare.us1.97

See more with Sales Intelligence

Accord Healthcare, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Accord Healthcare, Inc.

These are the website technologies, by industry, used by Accord Healthcare, Inc. top domains

Widget (6)

Twemoji

Advertising (2)

Google Adsense

Content Management System (2)

WordPress

Mobile (2)

Meta Viewport

More Technologies

4

See all

News & Signals from Accord Healthcare, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAccord Healthcare, Inc. launched Sugammadex Injection on Aug 5th '26.RALEIGH, N.C., Aug. 5, 2026 /PRNewswire/ - Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the launch of Sugammadex Injection, indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery.

NewsAccord Healthcare Inc launched Tadalafil Tablets on May 4th '26.RALEIGH, N.C., May 4, 2026 /PRNewswire/ - Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the relaunch of Tadalafil Tablets, an FDA-approved phosphodiesterase type 5 (PDE5) inhibitor for oral administration, available in multiple dosage strengths.

NewsAccord Healthcare Inc launched Lenalidomide Capsules on Feb 17th '26.RALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ - Accord Healthcare, Inc., a leading U.S. pharmaceutical company, today announced the launch of Lenalidomide Capsules in the United States, reinforcing the company's commitment to expanding access to high-quality, affordable oncology therapies for patients.